nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP3A4—Temozolomide—melanoma	0.178	0.385	CbGbCtD
Rivastigmine—CYP2D6—Vemurafenib—melanoma	0.153	0.332	CbGbCtD
Rivastigmine—CYP3A4—Vemurafenib—melanoma	0.0975	0.211	CbGbCtD
Rivastigmine—CYP3A4—Docetaxel—melanoma	0.0334	0.0724	CbGbCtD
Rivastigmine—Mediastinal disorder—Temozolomide—melanoma	0.000551	0.00111	CcSEcCtD
Rivastigmine—Erythema—Carmustine—melanoma	0.000551	0.00111	CcSEcCtD
Rivastigmine—Malnutrition—Carmustine—melanoma	0.000551	0.00111	CcSEcCtD
Rivastigmine—Cough—Bleomycin—melanoma	0.00055	0.00111	CcSEcCtD
Rivastigmine—Chills—Temozolomide—melanoma	0.000548	0.0011	CcSEcCtD
Rivastigmine—Dehydration—Docetaxel—melanoma	0.000546	0.0011	CcSEcCtD
Rivastigmine—Ill-defined disorder—Dactinomycin—melanoma	0.000546	0.0011	CcSEcCtD
Rivastigmine—Anaemia—Dactinomycin—melanoma	0.000544	0.00109	CcSEcCtD
Rivastigmine—Liver function test abnormal—Docetaxel—melanoma	0.000542	0.00109	CcSEcCtD
Rivastigmine—Vomiting—Vemurafenib—melanoma	0.00054	0.00109	CcSEcCtD
Rivastigmine—Alopecia—Temozolomide—melanoma	0.00054	0.00109	CcSEcCtD
Rivastigmine—Dry skin—Docetaxel—melanoma	0.000539	0.00108	CcSEcCtD
Rivastigmine—Chest pain—Bleomycin—melanoma	0.000537	0.00108	CcSEcCtD
Rivastigmine—Myalgia—Bleomycin—melanoma	0.000537	0.00108	CcSEcCtD
Rivastigmine—Abdominal pain upper—Docetaxel—melanoma	0.000537	0.00108	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Docetaxel—melanoma	0.000537	0.00108	CcSEcCtD
Rivastigmine—Rash—Vemurafenib—melanoma	0.000536	0.00108	CcSEcCtD
Rivastigmine—Mental disorder—Temozolomide—melanoma	0.000536	0.00108	CcSEcCtD
Rivastigmine—Dermatitis—Vemurafenib—melanoma	0.000535	0.00108	CcSEcCtD
Rivastigmine—Back pain—Carmustine—melanoma	0.000533	0.00107	CcSEcCtD
Rivastigmine—Headache—Vemurafenib—melanoma	0.000532	0.00107	CcSEcCtD
Rivastigmine—Malnutrition—Temozolomide—melanoma	0.000532	0.00107	CcSEcCtD
Rivastigmine—Erythema—Temozolomide—melanoma	0.000532	0.00107	CcSEcCtD
Rivastigmine—Breast disorder—Docetaxel—melanoma	0.000531	0.00107	CcSEcCtD
Rivastigmine—Discomfort—Bleomycin—melanoma	0.000531	0.00107	CcSEcCtD
Rivastigmine—Malaise—Dactinomycin—melanoma	0.000531	0.00107	CcSEcCtD
Rivastigmine—Cramp muscle—Docetaxel—melanoma	0.000529	0.00107	CcSEcCtD
Rivastigmine—Nasopharyngitis—Docetaxel—melanoma	0.000525	0.00106	CcSEcCtD
Rivastigmine—Dysgeusia—Temozolomide—melanoma	0.000521	0.00105	CcSEcCtD
Rivastigmine—Confusional state—Bleomycin—melanoma	0.000519	0.00105	CcSEcCtD
Rivastigmine—Vision blurred—Carmustine—melanoma	0.000519	0.00104	CcSEcCtD
Rivastigmine—Tremor—Carmustine—melanoma	0.000516	0.00104	CcSEcCtD
Rivastigmine—Oedema—Bleomycin—melanoma	0.000515	0.00104	CcSEcCtD
Rivastigmine—Back pain—Temozolomide—melanoma	0.000515	0.00104	CcSEcCtD
Rivastigmine—Infection—Bleomycin—melanoma	0.000511	0.00103	CcSEcCtD
Rivastigmine—Anaemia—Carmustine—melanoma	0.000509	0.00102	CcSEcCtD
Rivastigmine—Dysphagia—Docetaxel—melanoma	0.000508	0.00102	CcSEcCtD
Rivastigmine—Agitation—Carmustine—melanoma	0.000506	0.00102	CcSEcCtD
Rivastigmine—Nausea—Vemurafenib—melanoma	0.000505	0.00102	CcSEcCtD
Rivastigmine—Thrombocytopenia—Bleomycin—melanoma	0.000504	0.00101	CcSEcCtD
Rivastigmine—Vision blurred—Temozolomide—melanoma	0.000501	0.00101	CcSEcCtD
Rivastigmine—Myalgia—Dactinomycin—melanoma	0.000501	0.00101	CcSEcCtD
Rivastigmine—Bronchospasm—Docetaxel—melanoma	0.0005	0.00101	CcSEcCtD
Rivastigmine—Tremor—Temozolomide—melanoma	0.000499	0.001	CcSEcCtD
Rivastigmine—Discomfort—Dactinomycin—melanoma	0.000495	0.000996	CcSEcCtD
Rivastigmine—Angina pectoris—Docetaxel—melanoma	0.000495	0.000996	CcSEcCtD
Rivastigmine—Ill-defined disorder—Temozolomide—melanoma	0.000494	0.000994	CcSEcCtD
Rivastigmine—Anaemia—Temozolomide—melanoma	0.000492	0.00099	CcSEcCtD
Rivastigmine—Anorexia—Bleomycin—melanoma	0.000491	0.000988	CcSEcCtD
Rivastigmine—Agitation—Temozolomide—melanoma	0.000489	0.000985	CcSEcCtD
Rivastigmine—Hypotension—Bleomycin—melanoma	0.000481	0.000969	CcSEcCtD
Rivastigmine—Oedema—Dactinomycin—melanoma	0.00048	0.000967	CcSEcCtD
Rivastigmine—Malaise—Temozolomide—melanoma	0.00048	0.000966	CcSEcCtD
Rivastigmine—Vertigo—Temozolomide—melanoma	0.000478	0.000963	CcSEcCtD
Rivastigmine—Convulsion—Carmustine—melanoma	0.000477	0.000961	CcSEcCtD
Rivastigmine—Infection—Dactinomycin—melanoma	0.000477	0.00096	CcSEcCtD
Rivastigmine—Hypertension—Carmustine—melanoma	0.000475	0.000957	CcSEcCtD
Rivastigmine—Palpitations—Temozolomide—melanoma	0.00047	0.000947	CcSEcCtD
Rivastigmine—Thrombocytopenia—Dactinomycin—melanoma	0.00047	0.000947	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000469	0.000944	CcSEcCtD
Rivastigmine—Myalgia—Carmustine—melanoma	0.000469	0.000944	CcSEcCtD
Rivastigmine—Chest pain—Carmustine—melanoma	0.000469	0.000944	CcSEcCtD
Rivastigmine—Anxiety—Carmustine—melanoma	0.000467	0.000941	CcSEcCtD
Rivastigmine—Cough—Temozolomide—melanoma	0.000464	0.000935	CcSEcCtD
Rivastigmine—Paraesthesia—Bleomycin—melanoma	0.000462	0.000931	CcSEcCtD
Rivastigmine—Weight increased—Docetaxel—melanoma	0.000462	0.000931	CcSEcCtD
Rivastigmine—Convulsion—Temozolomide—melanoma	0.000461	0.000928	CcSEcCtD
Rivastigmine—Weight decreased—Docetaxel—melanoma	0.000459	0.000925	CcSEcCtD
Rivastigmine—Hypertension—Temozolomide—melanoma	0.000459	0.000925	CcSEcCtD
Rivastigmine—Dyspnoea—Bleomycin—melanoma	0.000459	0.000924	CcSEcCtD
Rivastigmine—Anorexia—Dactinomycin—melanoma	0.000458	0.000922	CcSEcCtD
Rivastigmine—Pneumonia—Docetaxel—melanoma	0.000455	0.000917	CcSEcCtD
Rivastigmine—Confusional state—Carmustine—melanoma	0.000453	0.000912	CcSEcCtD
Rivastigmine—Arthralgia—Temozolomide—melanoma	0.000453	0.000912	CcSEcCtD
Rivastigmine—Myalgia—Temozolomide—melanoma	0.000453	0.000912	CcSEcCtD
Rivastigmine—Infestation NOS—Docetaxel—melanoma	0.000453	0.000912	CcSEcCtD
Rivastigmine—Infestation—Docetaxel—melanoma	0.000453	0.000912	CcSEcCtD
Rivastigmine—Anxiety—Temozolomide—melanoma	0.000451	0.000909	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00045	0.000906	CcSEcCtD
Rivastigmine—Oedema—Carmustine—melanoma	0.000449	0.000905	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000449	0.000904	CcSEcCtD
Rivastigmine—Discomfort—Temozolomide—melanoma	0.000448	0.000901	CcSEcCtD
Rivastigmine—Decreased appetite—Bleomycin—melanoma	0.000448	0.000901	CcSEcCtD
Rivastigmine—Infection—Carmustine—melanoma	0.000446	0.000899	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Docetaxel—melanoma	0.000446	0.000899	CcSEcCtD
Rivastigmine—Renal failure—Docetaxel—melanoma	0.000445	0.000896	CcSEcCtD
Rivastigmine—Myocardial infarction—Docetaxel—melanoma	0.000444	0.000894	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Docetaxel—melanoma	0.000444	0.000894	CcSEcCtD
Rivastigmine—Dry mouth—Temozolomide—melanoma	0.000443	0.000892	CcSEcCtD
Rivastigmine—Pain—Bleomycin—melanoma	0.00044	0.000886	CcSEcCtD
Rivastigmine—Conjunctivitis—Docetaxel—melanoma	0.00044	0.000886	CcSEcCtD
Rivastigmine—Thrombocytopenia—Carmustine—melanoma	0.00044	0.000886	CcSEcCtD
Rivastigmine—Tachycardia—Carmustine—melanoma	0.000439	0.000883	CcSEcCtD
Rivastigmine—Confusional state—Temozolomide—melanoma	0.000438	0.000882	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000437	0.000881	CcSEcCtD
Rivastigmine—Oedema—Temozolomide—melanoma	0.000434	0.000874	CcSEcCtD
Rivastigmine—Infection—Temozolomide—melanoma	0.000431	0.000869	CcSEcCtD
Rivastigmine—Anorexia—Carmustine—melanoma	0.000428	0.000863	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Docetaxel—melanoma	0.000428	0.000862	CcSEcCtD
Rivastigmine—Epistaxis—Docetaxel—melanoma	0.000427	0.00086	CcSEcCtD
Rivastigmine—Nervous system disorder—Temozolomide—melanoma	0.000426	0.000858	CcSEcCtD
Rivastigmine—Thrombocytopenia—Temozolomide—melanoma	0.000425	0.000856	CcSEcCtD
Rivastigmine—Feeling abnormal—Bleomycin—melanoma	0.000424	0.000854	CcSEcCtD
Rivastigmine—Skin disorder—Temozolomide—melanoma	0.000422	0.000849	CcSEcCtD
Rivastigmine—Hypotension—Carmustine—melanoma	0.00042	0.000846	CcSEcCtD
Rivastigmine—Hyperhidrosis—Temozolomide—melanoma	0.00042	0.000845	CcSEcCtD
Rivastigmine—Decreased appetite—Dactinomycin—melanoma	0.000417	0.00084	CcSEcCtD
Rivastigmine—Fatigue—Dactinomycin—melanoma	0.000414	0.000834	CcSEcCtD
Rivastigmine—Anorexia—Temozolomide—melanoma	0.000414	0.000834	CcSEcCtD
Rivastigmine—Pain—Dactinomycin—melanoma	0.000411	0.000827	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Carmustine—melanoma	0.000409	0.000824	CcSEcCtD
Rivastigmine—Urticaria—Bleomycin—melanoma	0.000409	0.000823	CcSEcCtD
Rivastigmine—Haemoglobin—Docetaxel—melanoma	0.000409	0.000823	CcSEcCtD
Rivastigmine—Rhinitis—Docetaxel—melanoma	0.000408	0.000821	CcSEcCtD
Rivastigmine—Body temperature increased—Bleomycin—melanoma	0.000407	0.000819	CcSEcCtD
Rivastigmine—Hepatitis—Docetaxel—melanoma	0.000407	0.000818	CcSEcCtD
Rivastigmine—Haemorrhage—Docetaxel—melanoma	0.000407	0.000818	CcSEcCtD
Rivastigmine—Insomnia—Carmustine—melanoma	0.000406	0.000818	CcSEcCtD
Rivastigmine—Hypoaesthesia—Docetaxel—melanoma	0.000404	0.000814	CcSEcCtD
Rivastigmine—Paraesthesia—Carmustine—melanoma	0.000404	0.000812	CcSEcCtD
Rivastigmine—Pharyngitis—Docetaxel—melanoma	0.000403	0.000812	CcSEcCtD
Rivastigmine—Urinary tract disorder—Docetaxel—melanoma	0.000401	0.000808	CcSEcCtD
Rivastigmine—Dyspnoea—Carmustine—melanoma	0.000401	0.000807	CcSEcCtD
Rivastigmine—Oedema peripheral—Docetaxel—melanoma	0.0004	0.000806	CcSEcCtD
Rivastigmine—Somnolence—Carmustine—melanoma	0.0004	0.000804	CcSEcCtD
Rivastigmine—Connective tissue disorder—Docetaxel—melanoma	0.000399	0.000804	CcSEcCtD
Rivastigmine—Urethral disorder—Docetaxel—melanoma	0.000398	0.000802	CcSEcCtD
Rivastigmine—Feeling abnormal—Dactinomycin—melanoma	0.000396	0.000797	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000396	0.000797	CcSEcCtD
Rivastigmine—Insomnia—Temozolomide—melanoma	0.000393	0.000791	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Dactinomycin—melanoma	0.000393	0.000791	CcSEcCtD
Rivastigmine—Visual impairment—Docetaxel—melanoma	0.000392	0.000789	CcSEcCtD
Rivastigmine—Decreased appetite—Carmustine—melanoma	0.000391	0.000787	CcSEcCtD
Rivastigmine—Paraesthesia—Temozolomide—melanoma	0.00039	0.000785	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Carmustine—melanoma	0.000388	0.000781	CcSEcCtD
Rivastigmine—Dyspnoea—Temozolomide—melanoma	0.000387	0.00078	CcSEcCtD
Rivastigmine—Somnolence—Temozolomide—melanoma	0.000386	0.000777	CcSEcCtD
Rivastigmine—Erythema multiforme—Docetaxel—melanoma	0.000384	0.000774	CcSEcCtD
Rivastigmine—Pain—Carmustine—melanoma	0.000384	0.000774	CcSEcCtD
Rivastigmine—Constipation—Carmustine—melanoma	0.000384	0.000774	CcSEcCtD
Rivastigmine—Dyspepsia—Temozolomide—melanoma	0.000382	0.00077	CcSEcCtD
Rivastigmine—Eye disorder—Docetaxel—melanoma	0.00038	0.000765	CcSEcCtD
Rivastigmine—Abdominal pain—Dactinomycin—melanoma	0.00038	0.000764	CcSEcCtD
Rivastigmine—Body temperature increased—Dactinomycin—melanoma	0.00038	0.000764	CcSEcCtD
Rivastigmine—Hypersensitivity—Bleomycin—melanoma	0.000379	0.000764	CcSEcCtD
Rivastigmine—Decreased appetite—Temozolomide—melanoma	0.000378	0.00076	CcSEcCtD
Rivastigmine—Flushing—Docetaxel—melanoma	0.000377	0.00076	CcSEcCtD
Rivastigmine—Cardiac disorder—Docetaxel—melanoma	0.000377	0.00076	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Temozolomide—melanoma	0.000375	0.000755	CcSEcCtD
Rivastigmine—Fatigue—Temozolomide—melanoma	0.000374	0.000754	CcSEcCtD
Rivastigmine—Pain—Temozolomide—melanoma	0.000371	0.000748	CcSEcCtD
Rivastigmine—Constipation—Temozolomide—melanoma	0.000371	0.000748	CcSEcCtD
Rivastigmine—Feeling abnormal—Carmustine—melanoma	0.00037	0.000746	CcSEcCtD
Rivastigmine—Asthenia—Bleomycin—melanoma	0.000369	0.000744	CcSEcCtD
Rivastigmine—Angiopathy—Docetaxel—melanoma	0.000369	0.000743	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Carmustine—melanoma	0.000367	0.00074	CcSEcCtD
Rivastigmine—Mediastinal disorder—Docetaxel—melanoma	0.000366	0.000738	CcSEcCtD
Rivastigmine—Chills—Docetaxel—melanoma	0.000365	0.000734	CcSEcCtD
Rivastigmine—Pruritus—Bleomycin—melanoma	0.000364	0.000733	CcSEcCtD
Rivastigmine—Arrhythmia—Docetaxel—melanoma	0.000363	0.000731	CcSEcCtD
Rivastigmine—Alopecia—Docetaxel—melanoma	0.000359	0.000723	CcSEcCtD
Rivastigmine—Feeling abnormal—Temozolomide—melanoma	0.000358	0.000721	CcSEcCtD
Rivastigmine—Mental disorder—Docetaxel—melanoma	0.000356	0.000717	CcSEcCtD
Rivastigmine—Abdominal pain—Carmustine—melanoma	0.000355	0.000715	CcSEcCtD
Rivastigmine—Body temperature increased—Carmustine—melanoma	0.000355	0.000715	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Temozolomide—melanoma	0.000355	0.000715	CcSEcCtD
Rivastigmine—Erythema—Docetaxel—melanoma	0.000354	0.000713	CcSEcCtD
Rivastigmine—Malnutrition—Docetaxel—melanoma	0.000354	0.000713	CcSEcCtD
Rivastigmine—Hypersensitivity—Dactinomycin—melanoma	0.000354	0.000712	CcSEcCtD
Rivastigmine—Dysgeusia—Docetaxel—melanoma	0.000347	0.000698	CcSEcCtD
Rivastigmine—Urticaria—Temozolomide—melanoma	0.000345	0.000695	CcSEcCtD
Rivastigmine—Asthenia—Dactinomycin—melanoma	0.000344	0.000694	CcSEcCtD
Rivastigmine—Body temperature increased—Temozolomide—melanoma	0.000343	0.000691	CcSEcCtD
Rivastigmine—Abdominal pain—Temozolomide—melanoma	0.000343	0.000691	CcSEcCtD
Rivastigmine—Back pain—Docetaxel—melanoma	0.000342	0.000689	CcSEcCtD
Rivastigmine—Muscle spasms—Docetaxel—melanoma	0.00034	0.000685	CcSEcCtD
Rivastigmine—Hypersensitivity—Carmustine—melanoma	0.000331	0.000667	CcSEcCtD
Rivastigmine—Diarrhoea—Dactinomycin—melanoma	0.000329	0.000661	CcSEcCtD
Rivastigmine—Vomiting—Bleomycin—melanoma	0.000327	0.000659	CcSEcCtD
Rivastigmine—Anaemia—Docetaxel—melanoma	0.000327	0.000659	CcSEcCtD
Rivastigmine—Rash—Bleomycin—melanoma	0.000325	0.000654	CcSEcCtD
Rivastigmine—Dermatitis—Bleomycin—melanoma	0.000324	0.000653	CcSEcCtD
Rivastigmine—Asthenia—Carmustine—melanoma	0.000322	0.000649	CcSEcCtD
Rivastigmine—Hypersensitivity—Temozolomide—melanoma	0.00032	0.000644	CcSEcCtD
Rivastigmine—Syncope—Docetaxel—melanoma	0.000317	0.000639	CcSEcCtD
Rivastigmine—Palpitations—Docetaxel—melanoma	0.000313	0.00063	CcSEcCtD
Rivastigmine—Asthenia—Temozolomide—melanoma	0.000312	0.000627	CcSEcCtD
Rivastigmine—Loss of consciousness—Docetaxel—melanoma	0.000311	0.000626	CcSEcCtD
Rivastigmine—Cough—Docetaxel—melanoma	0.000309	0.000622	CcSEcCtD
Rivastigmine—Diarrhoea—Carmustine—melanoma	0.000307	0.000619	CcSEcCtD
Rivastigmine—Pruritus—Temozolomide—melanoma	0.000307	0.000619	CcSEcCtD
Rivastigmine—Convulsion—Docetaxel—melanoma	0.000307	0.000617	CcSEcCtD
Rivastigmine—Nausea—Bleomycin—melanoma	0.000306	0.000616	CcSEcCtD
Rivastigmine—Hypertension—Docetaxel—melanoma	0.000306	0.000615	CcSEcCtD
Rivastigmine—Vomiting—Dactinomycin—melanoma	0.000305	0.000615	CcSEcCtD
Rivastigmine—Rash—Dactinomycin—melanoma	0.000303	0.00061	CcSEcCtD
Rivastigmine—Arthralgia—Docetaxel—melanoma	0.000301	0.000607	CcSEcCtD
Rivastigmine—Myalgia—Docetaxel—melanoma	0.000301	0.000607	CcSEcCtD
Rivastigmine—Chest pain—Docetaxel—melanoma	0.000301	0.000607	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000299	0.000602	CcSEcCtD
Rivastigmine—Dizziness—Carmustine—melanoma	0.000297	0.000598	CcSEcCtD
Rivastigmine—Diarrhoea—Temozolomide—melanoma	0.000297	0.000598	CcSEcCtD
Rivastigmine—Dry mouth—Docetaxel—melanoma	0.000295	0.000593	CcSEcCtD
Rivastigmine—Confusional state—Docetaxel—melanoma	0.000291	0.000586	CcSEcCtD
Rivastigmine—Oedema—Docetaxel—melanoma	0.000289	0.000581	CcSEcCtD
Rivastigmine—Dizziness—Temozolomide—melanoma	0.000287	0.000578	CcSEcCtD
Rivastigmine—Infection—Docetaxel—melanoma	0.000287	0.000578	CcSEcCtD
Rivastigmine—Vomiting—Carmustine—melanoma	0.000286	0.000575	CcSEcCtD
Rivastigmine—Nausea—Dactinomycin—melanoma	0.000285	0.000574	CcSEcCtD
Rivastigmine—Shock—Docetaxel—melanoma	0.000284	0.000572	CcSEcCtD
Rivastigmine—Rash—Carmustine—melanoma	0.000283	0.000571	CcSEcCtD
Rivastigmine—Nervous system disorder—Docetaxel—melanoma	0.000283	0.00057	CcSEcCtD
Rivastigmine—Dermatitis—Carmustine—melanoma	0.000283	0.00057	CcSEcCtD
Rivastigmine—Thrombocytopenia—Docetaxel—melanoma	0.000283	0.000569	CcSEcCtD
Rivastigmine—Tachycardia—Docetaxel—melanoma	0.000282	0.000568	CcSEcCtD
Rivastigmine—Headache—Carmustine—melanoma	0.000282	0.000567	CcSEcCtD
Rivastigmine—Skin disorder—Docetaxel—melanoma	0.000281	0.000565	CcSEcCtD
Rivastigmine—Vomiting—Temozolomide—melanoma	0.000276	0.000556	CcSEcCtD
Rivastigmine—Anorexia—Docetaxel—melanoma	0.000275	0.000554	CcSEcCtD
Rivastigmine—Rash—Temozolomide—melanoma	0.000274	0.000551	CcSEcCtD
Rivastigmine—Dermatitis—Temozolomide—melanoma	0.000274	0.000551	CcSEcCtD
Rivastigmine—Headache—Temozolomide—melanoma	0.000272	0.000548	CcSEcCtD
Rivastigmine—Hypotension—Docetaxel—melanoma	0.00027	0.000543	CcSEcCtD
Rivastigmine—Nausea—Carmustine—melanoma	0.000267	0.000537	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000263	0.00053	CcSEcCtD
Rivastigmine—Insomnia—Docetaxel—melanoma	0.000261	0.000526	CcSEcCtD
Rivastigmine—Paraesthesia—Docetaxel—melanoma	0.000259	0.000522	CcSEcCtD
Rivastigmine—Nausea—Temozolomide—melanoma	0.000258	0.000519	CcSEcCtD
Rivastigmine—Dyspnoea—Docetaxel—melanoma	0.000257	0.000518	CcSEcCtD
Rivastigmine—Somnolence—Docetaxel—melanoma	0.000257	0.000517	CcSEcCtD
Rivastigmine—Dyspepsia—Docetaxel—melanoma	0.000254	0.000512	CcSEcCtD
Rivastigmine—Decreased appetite—Docetaxel—melanoma	0.000251	0.000505	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Docetaxel—melanoma	0.000249	0.000502	CcSEcCtD
Rivastigmine—Fatigue—Docetaxel—melanoma	0.000249	0.000501	CcSEcCtD
Rivastigmine—Constipation—Docetaxel—melanoma	0.000247	0.000497	CcSEcCtD
Rivastigmine—Pain—Docetaxel—melanoma	0.000247	0.000497	CcSEcCtD
Rivastigmine—Feeling abnormal—Docetaxel—melanoma	0.000238	0.000479	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Docetaxel—melanoma	0.000236	0.000476	CcSEcCtD
Rivastigmine—Body temperature increased—Docetaxel—melanoma	0.000228	0.00046	CcSEcCtD
Rivastigmine—Abdominal pain—Docetaxel—melanoma	0.000228	0.00046	CcSEcCtD
Rivastigmine—Neostigmine—ABCB1—melanoma	0.000226	1	CrCbGaD
Rivastigmine—Hypersensitivity—Docetaxel—melanoma	0.000213	0.000428	CcSEcCtD
Rivastigmine—Asthenia—Docetaxel—melanoma	0.000207	0.000417	CcSEcCtD
Rivastigmine—Pruritus—Docetaxel—melanoma	0.000204	0.000411	CcSEcCtD
Rivastigmine—Diarrhoea—Docetaxel—melanoma	0.000198	0.000398	CcSEcCtD
Rivastigmine—Dizziness—Docetaxel—melanoma	0.000191	0.000385	CcSEcCtD
Rivastigmine—Vomiting—Docetaxel—melanoma	0.000184	0.00037	CcSEcCtD
Rivastigmine—Rash—Docetaxel—melanoma	0.000182	0.000367	CcSEcCtD
Rivastigmine—Dermatitis—Docetaxel—melanoma	0.000182	0.000366	CcSEcCtD
Rivastigmine—Headache—Docetaxel—melanoma	0.000181	0.000364	CcSEcCtD
Rivastigmine—Nausea—Docetaxel—melanoma	0.000172	0.000345	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	9.91e-05	0.00241	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	9.82e-05	0.00239	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	9.78e-05	0.00238	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—PRKCA—melanoma	9.77e-05	0.00238	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ACER3—melanoma	9.7e-05	0.00236	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ATM—melanoma	9.5e-05	0.00231	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	9.46e-05	0.0023	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—melanoma	9.43e-05	0.00229	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HS3ST5—melanoma	9.24e-05	0.00225	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	9.17e-05	0.00223	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CD—melanoma	9.06e-05	0.0022	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPS3—melanoma	9.04e-05	0.0022	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—melanoma	8.9e-05	0.00217	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—UGT2B10—melanoma	8.87e-05	0.00216	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CB—melanoma	8.85e-05	0.00215	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—melanoma	8.8e-05	0.00214	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	8.76e-05	0.00213	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—PRKCA—melanoma	8.39e-05	0.00204	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	8.29e-05	0.00202	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HS3ST5—melanoma	8.25e-05	0.00201	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	8.23e-05	0.002	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	8.15e-05	0.00198	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—BRAF—melanoma	8.07e-05	0.00196	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP17A1—melanoma	7.95e-05	0.00193	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CB—melanoma	7.89e-05	0.00192	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	7.88e-05	0.00192	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	7.84e-05	0.00191	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PTEN—melanoma	7.65e-05	0.00186	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	7.49e-05	0.00182	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—PRKCA—melanoma	7.49e-05	0.00182	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.44e-05	0.00181	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	7.2e-05	0.00175	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	7.12e-05	0.00173	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.01e-05	0.00171	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLCB4—melanoma	7.01e-05	0.0017	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	6.91e-05	0.00168	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—FASN—melanoma	6.88e-05	0.00167	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PTEN—melanoma	6.82e-05	0.00166	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	6.76e-05	0.00164	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—MDM2—melanoma	6.76e-05	0.00164	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP1B1—melanoma	6.69e-05	0.00163	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6.64e-05	0.00162	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	6.6e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIP4K2A—melanoma	6.59e-05	0.0016	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC6A11—melanoma	6.59e-05	0.0016	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—PAX6—melanoma	6.46e-05	0.00157	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTAP—melanoma	6.41e-05	0.00156	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.4e-05	0.00156	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.27e-05	0.00153	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.26e-05	0.00152	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLCB4—melanoma	6.25e-05	0.00152	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—HSPA5—melanoma	6.21e-05	0.00151	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—BRAF—melanoma	6.18e-05	0.0015	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	6.13e-05	0.00149	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.11e-05	0.00149	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.05e-05	0.00147	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	6.03e-05	0.00147	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.91e-05	0.00144	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.89e-05	0.00143	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIP4K2A—melanoma	5.88e-05	0.00143	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC6A11—melanoma	5.88e-05	0.00143	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	5.87e-05	0.00143	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.87e-05	0.00143	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—PAX6—melanoma	5.77e-05	0.0014	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTAP—melanoma	5.72e-05	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PHGDH—melanoma	5.71e-05	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—LUM—melanoma	5.71e-05	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HPSE—melanoma	5.6e-05	0.00136	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.59e-05	0.00136	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—HSPA5—melanoma	5.54e-05	0.00135	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—BRAF—melanoma	5.51e-05	0.00134	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CUBN—melanoma	5.5e-05	0.00134	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CA—melanoma	5.39e-05	0.00131	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.32e-05	0.0013	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—BSG—melanoma	5.31e-05	0.00129	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SDHD—melanoma	5.31e-05	0.00129	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CSPG4—melanoma	5.31e-05	0.00129	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP17A1—melanoma	5.2e-05	0.00126	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MDM2—melanoma	5.18e-05	0.00126	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GPAM—melanoma	5.14e-05	0.00125	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	5.12e-05	0.00125	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PHGDH—melanoma	5.1e-05	0.00124	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—LUM—melanoma	5.1e-05	0.00124	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.04e-05	0.00123	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HPSE—melanoma	5e-05	0.00122	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CUBN—melanoma	4.9e-05	0.00119	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.9e-05	0.00119	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—melanoma	4.81e-05	0.00117	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.79e-05	0.00117	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.79e-05	0.00117	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SDHD—melanoma	4.74e-05	0.00115	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CSPG4—melanoma	4.74e-05	0.00115	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—BSG—melanoma	4.74e-05	0.00115	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—MDM2—melanoma	4.62e-05	0.00112	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—MAPK1—melanoma	4.62e-05	0.00112	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GPAM—melanoma	4.59e-05	0.00112	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.56e-05	0.00111	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.53e-05	0.0011	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACER3—melanoma	4.46e-05	0.00109	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.37e-05	0.00106	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLA2G6—melanoma	4.37e-05	0.00106	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	4.31e-05	0.00105	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.16e-05	0.00101	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	4.12e-05	0.001	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—UGT2B10—melanoma	4.08e-05	0.000993	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.02e-05	0.000979	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—VCAN—melanoma	3.93e-05	0.000956	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLA2G6—melanoma	3.9e-05	0.000949	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HS3ST5—melanoma	3.79e-05	0.000923	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.72e-05	0.000905	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—HRAS—melanoma	3.71e-05	0.000902	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP1—melanoma	3.68e-05	0.000895	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.59e-05	0.000873	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MAPK1—melanoma	3.54e-05	0.000861	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—VCAN—melanoma	3.5e-05	0.000853	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.4e-05	0.000827	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.32e-05	0.000807	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP17A1—melanoma	3.31e-05	0.000806	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	3.31e-05	0.000805	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP1—melanoma	3.28e-05	0.000799	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.27e-05	0.000795	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—melanoma	3.23e-05	0.000785	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.2e-05	0.000779	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—MAPK1—melanoma	3.16e-05	0.000768	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GNA11—melanoma	3.13e-05	0.000761	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—FASN—melanoma	3.06e-05	0.000745	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC5A5—melanoma	3.01e-05	0.000733	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP17A1—melanoma	2.96e-05	0.000719	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF1—melanoma	2.94e-05	0.000716	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACER3—melanoma	2.92e-05	0.00071	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.92e-05	0.000709	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CD44—melanoma	2.91e-05	0.000708	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GNAQ—melanoma	2.91e-05	0.000708	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	2.88e-05	0.0007	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLCB4—melanoma	2.87e-05	0.000699	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.85e-05	0.000693	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP2—melanoma	2.85e-05	0.000693	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—HRAS—melanoma	2.84e-05	0.000691	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.82e-05	0.000687	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GNA11—melanoma	2.79e-05	0.000679	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1B1—melanoma	2.79e-05	0.000679	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—FASN—melanoma	2.73e-05	0.000665	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC6A11—melanoma	2.7e-05	0.000657	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIP4K2A—melanoma	2.7e-05	0.000657	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC5A5—melanoma	2.69e-05	0.000654	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UGT2B10—melanoma	2.67e-05	0.000649	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTAP—melanoma	2.63e-05	0.00064	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF1—melanoma	2.62e-05	0.000639	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GNAQ—melanoma	2.6e-05	0.000632	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CD44—melanoma	2.6e-05	0.000632	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.54e-05	0.000618	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP2—melanoma	2.54e-05	0.000618	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—HRAS—melanoma	2.53e-05	0.000617	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.52e-05	0.000613	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1B1—melanoma	2.49e-05	0.000605	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HS3ST5—melanoma	2.48e-05	0.000603	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.46e-05	0.000599	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CXCL8—melanoma	2.37e-05	0.000576	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PHGDH—melanoma	2.34e-05	0.00057	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LUM—melanoma	2.34e-05	0.00057	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HPSE—melanoma	2.3e-05	0.000559	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCB1—melanoma	2.3e-05	0.000559	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CUBN—melanoma	2.25e-05	0.000549	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.2e-05	0.000534	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CTNNB1—melanoma	2.18e-05	0.000531	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CSPG4—melanoma	2.18e-05	0.00053	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—BSG—melanoma	2.18e-05	0.00053	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SDHD—melanoma	2.18e-05	0.00053	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PRKCA—melanoma	2.11e-05	0.000514	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CXCL8—melanoma	2.11e-05	0.000514	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GPAM—melanoma	2.11e-05	0.000513	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ERCC2—melanoma	2.1e-05	0.00051	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCB1—melanoma	2.05e-05	0.000499	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CTNNB1—melanoma	1.95e-05	0.000474	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PRKCA—melanoma	1.89e-05	0.000459	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLCB4—melanoma	1.88e-05	0.000457	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ERCC2—melanoma	1.87e-05	0.000455	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLA2G6—melanoma	1.79e-05	0.000436	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC6A11—melanoma	1.77e-05	0.00043	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.77e-05	0.00043	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.74e-05	0.000423	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTAP—melanoma	1.72e-05	0.000418	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CG—melanoma	1.66e-05	0.000403	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—VCAN—melanoma	1.61e-05	0.000392	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARG—melanoma	1.6e-05	0.000389	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.55e-05	0.000377	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PHGDH—melanoma	1.53e-05	0.000373	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LUM—melanoma	1.53e-05	0.000373	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HPSE—melanoma	1.5e-05	0.000366	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CG—melanoma	1.48e-05	0.000359	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CUBN—melanoma	1.47e-05	0.000359	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CD—melanoma	1.46e-05	0.000354	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALB—melanoma	1.44e-05	0.00035	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARG—melanoma	1.43e-05	0.000347	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SDHD—melanoma	1.42e-05	0.000346	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CSPG4—melanoma	1.42e-05	0.000346	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—BSG—melanoma	1.42e-05	0.000346	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GPAM—melanoma	1.38e-05	0.000336	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP17A1—melanoma	1.36e-05	0.000331	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CD—melanoma	1.3e-05	0.000316	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GNA11—melanoma	1.28e-05	0.000312	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALB—melanoma	1.28e-05	0.000312	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CB—melanoma	1.27e-05	0.000309	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—melanoma	1.26e-05	0.000306	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—FASN—melanoma	1.26e-05	0.000306	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC5A5—melanoma	1.24e-05	0.000301	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GNAQ—melanoma	1.19e-05	0.00029	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CD44—melanoma	1.19e-05	0.00029	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLA2G6—melanoma	1.17e-05	0.000285	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1B1—melanoma	1.14e-05	0.000278	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CB—melanoma	1.13e-05	0.000275	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—melanoma	1.12e-05	0.000273	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTEN—melanoma	1.1e-05	0.000267	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—VCAN—melanoma	1.05e-05	0.000256	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTEN—melanoma	9.78e-06	0.000238	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCB1—melanoma	9.42e-06	0.000229	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP17A1—melanoma	8.89e-06	0.000216	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PRKCA—melanoma	8.67e-06	0.000211	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ERCC2—melanoma	8.6e-06	0.000209	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GNA11—melanoma	8.39e-06	0.000204	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FASN—melanoma	8.21e-06	0.0002	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC5A5—melanoma	8.08e-06	0.000197	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GNAQ—melanoma	7.8e-06	0.00019	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CD44—melanoma	7.8e-06	0.00019	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—melanoma	7.73e-06	0.000188	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1B1—melanoma	7.48e-06	0.000182	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—melanoma	6.9e-06	0.000168	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CG—melanoma	6.79e-06	0.000165	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARG—melanoma	6.55e-06	0.000159	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—melanoma	6.32e-06	0.000154	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCB1—melanoma	6.16e-06	0.00015	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CD—melanoma	5.97e-06	0.000145	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALB—melanoma	5.89e-06	0.000143	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PRKCA—melanoma	5.67e-06	0.000138	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—melanoma	5.64e-06	0.000137	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ERCC2—melanoma	5.62e-06	0.000137	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CB—melanoma	5.2e-06	0.000127	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—melanoma	5.16e-06	0.000125	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTEN—melanoma	4.5e-06	0.000109	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CG—melanoma	4.44e-06	0.000108	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARG—melanoma	4.29e-06	0.000104	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CD—melanoma	3.9e-06	9.5e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALB—melanoma	3.85e-06	9.38e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CB—melanoma	3.4e-06	8.28e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—melanoma	3.37e-06	8.2e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—melanoma	3.17e-06	7.72e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTEN—melanoma	2.94e-06	7.15e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—melanoma	2.59e-06	6.31e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—melanoma	2.07e-06	5.05e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—melanoma	1.69e-06	4.12e-05	CbGpPWpGaD
